
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS4521ASM) is a sirolimus-eluting coronary stent system designed for percutaneous coronary intervention. This configuration features a 4.50 mm expanded diameter and a 21 mm stent length, intended for treatment of de novo lesions in larger coronary vessels. The Ultimaster Nagomi platform builds on the Ultimaster family with an abluminal bioresorbable polymer coating engineered to release sirolimus and then resorb, leaving a bare-metal-like surface.
Key Features
- Drug: Sirolimus (limus-class antiproliferative)
- Polymer: Abluminal bioresorbable PDLLA-PCL coating
- Stent material: Cobalt-chromium alloy thin-strut platform
- Design: Open-cell hybrid architecture intended to support conformability and side-branch access
- Delivery system: Rapid-exchange monorail balloon catheter
- Size: 4.50 mm diameter x 21 mm length
- Single-use, sterile device
Clinical Applications
- Percutaneous coronary intervention (PCI) in native coronary arteries
- Treatment of de novo coronary artery lesions in larger-diameter reference vessels
- Use in patients suitable for drug-eluting stent therapy per operator discretion
- Support for complex anatomy where a conformable thin-strut DES is desired
Product Information
- Brand: Terumo
- Product line: Ultimaster Nagomi
- Category: Coronary Stents (Drug-Eluting)
- REF / UPN: DE-RS4521ASM
- Expanded diameter: 4.50 mm
- Stent length: 21 mm
- Guidewire compatibility: 0.014 in
- Delivery system: Rapid exchange
- Minimum guide catheter ID: Not specified in the located sources
- Rated burst pressure: Not specified in the located sources
- Shelf life and storage: Refer to manufacturer IFU
- Regulatory status: Refer to regional Terumo documentation for market-specific availability
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.